BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19124656)

  • 21. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
    Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
    Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.
    De Luca A; Carpanese D; Rapanotti MC; Viguria TM; Forgione MA; Rotili D; Fulci C; Iorio E; Quintieri L; Chimenti S; Bianchi L; Rosato A; Caccuri AM
    Oncotarget; 2017 Feb; 8(9):15520-15538. PubMed ID: 28107182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZNF750 inhibits the proliferation and invasion of melanoma cells through modulating the Wnt/b-catenin signaling pathway.
    Du Y; Lv G; Jing C; Liu J; Liu J
    Folia Histochem Cytobiol; 2020; 58(4):255-263. PubMed ID: 33185885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1.
    Maiques O; Barceló C; Panosa A; Pijuan J; Orgaz JL; Rodriguez-Hernandez I; Matas-Nadal C; Tell G; Vilella R; Fabra A; Puig S; Sanz-Moreno V; Matias-Guiu X; Canti C; Herreros J; Marti RM; Macià A
    Pigment Cell Melanoma Res; 2018 Jul; 31(4):484-495. PubMed ID: 29385656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
    Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
    Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
    Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Snail1 mediates hypoxia-induced melanoma progression.
    Liu S; Kumar SM; Martin JS; Yang R; Xu X
    Am J Pathol; 2011 Dec; 179(6):3020-31. PubMed ID: 21996677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.
    Poser I; Domínguez D; de Herreros AG; Varnai A; Buettner R; Bosserhoff AK
    J Biol Chem; 2001 Jul; 276(27):24661-6. PubMed ID: 11323412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.
    Liang HL; Hu AP; Li SL; Xie JP; Ma QZ; Liu JY
    Asian Pac J Cancer Prev; 2015; 16(6):2397-402. PubMed ID: 25824771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The plasma membrane Ca
    Hegedũs L; Garay T; Molnár E; Varga K; Bilecz Á; Török S; Padányi R; Pászty K; Wolf M; Grusch M; Kállay E; Döme B; Berger W; Hegedũs B; Enyedi A
    Int J Cancer; 2017 Jun; 140(12):2758-2770. PubMed ID: 27813079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
    Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
    Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.
    La T; Jin L; Liu XY; Song ZH; Farrelly M; Feng YC; Yan XG; Zhang YY; Thorne RF; Zhang XD; Teng L
    Oncol Res; 2020 Sep; 28(4):385-398. PubMed ID: 32252875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenes in melanoma.
    Polsky D; Cordon-Cardo C
    Oncogene; 2003 May; 22(20):3087-91. PubMed ID: 12789285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
    Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
    J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin.
    Wickström SA; Masoumi KC; Khochbin S; Fässler R; Massoumi R
    EMBO J; 2010 Jan; 29(1):131-44. PubMed ID: 19893491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma.
    Bosserhoff AK; Ellmann L; Quast AS; Eberle J; Boyle GM; Kuphal S
    Mol Carcinog; 2014 Aug; 53(8):635-47. PubMed ID: 23625515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.
    Rocha S; Martin AM; Meek DW; Perkins ND
    Mol Cell Biol; 2003 Jul; 23(13):4713-27. PubMed ID: 12808109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.